PRRT2
PRRT2 (Proline Rich Transmembrane Protein 2) is a protein that in humans is encoded by the PRRT2 gene. It is primarily associated with neurological disorders, including paroxysmal kinesigenic dyskinesia and infantile convulsions.
Function[edit]
The PRRT2 protein is a member of the proline-rich proteins family. It is a transmembrane protein that is thought to play a role in synaptic exocytosis and neurotransmitter release, although the exact function is not fully understood.
Clinical significance[edit]
Mutations in the PRRT2 gene are associated with a variety of neurological disorders. These include:
- Paroxysmal kinesigenic dyskinesia (PKD): This is the most common condition associated with PRRT2 mutations. PKD is a movement disorder characterized by involuntary movements triggered by sudden motion.
- Infantile convulsions: PRRT2 mutations can also cause a form of epilepsy known as benign familial infantile epilepsy (BFIE). This condition typically begins in infancy and resolves by age 2.
- Hemiplegic migraine: Some individuals with PRRT2 mutations experience this type of migraine, which involves temporary paralysis or sensory changes on one side of the body before or during a headache.
Genetics[edit]
The PRRT2 gene is located on the short (p) arm of chromosome 16 at position 11.2. It is inherited in an autosomal dominant manner, which means one copy of the altered gene in each cell is sufficient to cause the disorder.
Diagnosis[edit]
Diagnosis of conditions associated with PRRT2 mutations is based on clinical symptoms and confirmed by genetic testing.
Treatment[edit]
Treatment for conditions associated with PRRT2 mutations is symptomatic and may include medications to control seizures or movement disorders.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian